Drug information for HYCODAN

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
SYRUP; ORAL 1.5MG/5ML;5MG/5ML Discontinued   HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE Hydrocodone ENDO PHARMS 5213
2009-02-04 Label
2009-01-30 Letter
TABLET; ORAL 1.5MG;5MG Discontinued   HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE Hydrocodone ENDO PHARMS   "

Drug Adverse Effects information for HYCODAN

Role code Indications Reaction # Reports
C BLOOD CHOLESTEROL ABNORMAL BURSITIS 1
C COLITIS ULCERATIVE INTERSTITIAL LUNG DISEASE 6
C COLITIS ULCERATIVE PNEUMONITIS 6
C DYSPEPSIA CHOLECYSTITIS 1
C DYSPEPSIA DYSPNOEA 1
C DYSPEPSIA PAIN 1
C DYSPEPSIA VOMITING 1
C DYSPEPSIA VOMITING PSYCHOGENIC 1
C MENSTRUAL CYCLE MANAGEMENT CHOLECYSTITIS 1
C MENSTRUAL CYCLE MANAGEMENT DYSPNOEA 1
C MENSTRUAL CYCLE MANAGEMENT PAIN 1
C MENSTRUAL CYCLE MANAGEMENT VOMITING 1
C MENSTRUAL CYCLE MANAGEMENT VOMITING PSYCHOGENIC 1
C NON-SMALL CELL LUNG CANCER ATAXIA 1
C NON-SMALL CELL LUNG CANCER DYSPNOEA 1
C NON-SMALL CELL LUNG CANCER FATIGUE 1
C NON-SMALL CELL LUNG CANCER HEADACHE 1
C NON-SMALL CELL LUNG CANCER HYPERSENSITIVITY 1
C NON-SMALL CELL LUNG CANCER SYNCOPE 1
C POSTMENOPAUSE BURSITIS 1
C PREMENSTRUAL SYNDROME CHOLECYSTITIS 1
C PREMENSTRUAL SYNDROME DYSPNOEA 1
C PREMENSTRUAL SYNDROME PAIN 1
C PREMENSTRUAL SYNDROME VOMITING 1
C PREMENSTRUAL SYNDROME VOMITING PSYCHOGENIC 1
C RENAL CANCER METASTATIC ARRHYTHMIA SUPRAVENTRICULAR 1
C RENAL CANCER METASTATIC DYSPNOEA 1
C RENAL CANCER METASTATIC HAEMOTHORAX 1
C THYROIDECTOMY BURSITIS 1
C VOCAL CORD PARALYSIS BURSITIS 1
Ads by Google